# Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9

> **NCT00575224** · PHASE4 · COMPLETED · sponsor: **Pacific Health Foundation** · enrollment: 60 (actual)

## Conditions studied

- Chronic Hepatitis C
- Asian Americans
- Novel Genotypes
- Treatment

## Interventions

- **DRUG:** Pegylated interferon and ribavirin

## Key facts

- **NCT ID:** NCT00575224
- **Lead sponsor:** Pacific Health Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-10
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2009-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00575224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00575224, "Pegasys and Copegus for Asian Patients With Treatment-naive Hepatitis C Genotypes 6, 7, 8, 9". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00575224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*